288 related articles for article (PubMed ID: 26735544)
1. Chinese Herbal Medicine for Improving Quality of Life Among Nonsmall Cell Lung Cancer Patients: Overview of Systematic Reviews and Network Meta-Analysis.
Wu X; Chung VCH; Lu P; Poon SK; Hui EP; Lau AYL; Balneaves LG; Wong SYS; Wu JCY
Medicine (Baltimore); 2016 Jan; 95(1):e2410. PubMed ID: 26735544
[TBL] [Abstract][Full Text] [Related]
2. Injectable Chinese herbal formula Kang'ai for nonsmall cell lung cancer: Trial sequential analysis of 2,259 participants from 31 randomized controlled trials.
He XR; Han SY; Li PP
J Cancer Res Ther; 2016; 12(2):735-43. PubMed ID: 27461643
[TBL] [Abstract][Full Text] [Related]
3. The effect of comprehensive rehabilitation program plus chemotherapy on quality of life in patients with postoperative non-small-cell lung cancer: study protocol of a multicenter randomized clinical trial.
Yao J; Jiao L; Yao Y; Lu Y; Shi J; Li J; Chen P; Xu L; Gong Y
Trials; 2020 Apr; 21(1):309. PubMed ID: 32245480
[TBL] [Abstract][Full Text] [Related]
4. Chinese Herbal Medicine and Salmeterol and Fluticasone Propionate for Chronic Obstructive Pulmonary Disease: Systematic Review and Network Meta-Analysis.
Chung VCH; Wu X; Ma PHX; Ho RST; Poon SK; Hui DS; Wong SYS; Wu JCY
Medicine (Baltimore); 2016 May; 95(20):e3702. PubMed ID: 27196484
[TBL] [Abstract][Full Text] [Related]
5. Systematic review and meta-analysis of Chinese herbal medicine as adjuvant treatment in advanced non-small cell lung cancer patients.
Wang LC; Chang YY; Lee IC; Kuo HC; Tsai MY
Complement Ther Med; 2020 Aug; 52():102472. PubMed ID: 32951722
[TBL] [Abstract][Full Text] [Related]
6. Oral Chinese herbal medicine (CHM) as an adjuvant treatment during chemotherapy for non-small cell lung cancer: A systematic review.
Chen S; Flower A; Ritchie A; Liu J; Molassiotis A; Yu H; Lewith G
Lung Cancer; 2010 May; 68(2):137-45. PubMed ID: 20015572
[TBL] [Abstract][Full Text] [Related]
7. Adjunctive effect of compound Kushen Injection to chemotherapy for non-small cell lung cancer: An evidence map and overview of systematic reviews.
Yu ZY; Peng RY; Han M; Grant S; Yang GY; Liu JP; Cao HJ
J Ethnopharmacol; 2021 Dec; 281():114538. PubMed ID: 34418510
[TBL] [Abstract][Full Text] [Related]
8. Aidi injection plus platinum-based chemotherapy for stage IIIB/IV non-small cell lung cancer: A meta-analysis of 42 RCTs following the PRISMA guidelines.
Wang J; Li G; Yu L; Mo T; Wu Q; Zhou Z
J Ethnopharmacol; 2018 Jul; 221():137-150. PubMed ID: 29655852
[TBL] [Abstract][Full Text] [Related]
9. Effects of Shengmai injection add-on therapy to chemotherapy in patients with non-small cell lung cancer: a meta-analysis.
Duan B; Xie J; Rui Q; Zhang W; Xi Z
Support Care Cancer; 2018 Jul; 26(7):2103-2111. PubMed ID: 29594484
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy and safety of Aidi injection plus paclitaxel-based chemotherapy for advanced non-small cell lung cancer: A meta-analysis of 31 randomized controlled trials following the PRISMA guidelines.
Xiao Z; Wang C; Zhou M; Hu S; Jiang Y; Huang X; Li N; Feng J; Tang F; Chen X; Ding J; Chen L; Wang Y; Li X
J Ethnopharmacol; 2019 Jan; 228():110-122. PubMed ID: 30243827
[TBL] [Abstract][Full Text] [Related]
11. Compound Kushen injection plus platinum-based chemotherapy for stage IIIB/IV non-small cell lung cancer: A protocol for meta-analysis of randomized clinical trials following the PRISMA guidelines.
Chen H; Yao X; Li T; Lam CW; Zhang H; Wang J; Zhang W; Leung EL; Wu Q
Medicine (Baltimore); 2019 Dec; 98(52):e18552. PubMed ID: 31876753
[TBL] [Abstract][Full Text] [Related]
12. Kanglaite injection plus platinum-based chemotherapy for stage III/IV non-small cell lung cancer: A meta-analysis of 27 RCTs.
Huang X; Wang J; Lin W; Zhang N; Du J; Long Z; Yang Y; Zheng B; Zhong F; Wu Q; Ma W
Phytomedicine; 2020 Feb; 67():153154. PubMed ID: 31926475
[TBL] [Abstract][Full Text] [Related]
13. Aidi injection as adjunctive treatment to gemcitabine-based chemotherapy for advanced non-small cell lung cancer: a systematic review and meta-analysis.
Guo S; Li Y; Su H; Meng M; Xi J; Mo G; Chen X
Pharm Biol; 2021 Dec; 59(1):1260-1275. PubMed ID: 34541998
[TBL] [Abstract][Full Text] [Related]
14. Chinese herbal medicine as adjuvant treatment to chemotherapy for multidrug-resistant tuberculosis (MDR-TB): A systematic review of randomised clinical trials.
Wang M; Guan X; Chi Y; Robinson N; Liu JP
Tuberculosis (Edinb); 2015 Jul; 95(4):364-72. PubMed ID: 25861717
[TBL] [Abstract][Full Text] [Related]
15. [Overview of systematic reviews and Meta-analysis of Aidi Injection combined with chemotherapy in treatment of non-small cell lung cancer].
Gui YR; Fan BJ; Li JL; Wang S; Dong J; Hou W
Zhongguo Zhong Yao Za Zhi; 2022 Jul; 47(14):3923-3932. PubMed ID: 35850851
[TBL] [Abstract][Full Text] [Related]
16. Fuzheng Kang'ai decoction combined with gefitinib in advanced non-small cell lung cancer patients with epidermal growth factor receptor mutations: study protocol for a randomized controlled trial.
Yang XB; Wu WY; Long SQ; Deng H; Pan ZQ; He WF; Zhou YS; Liao GY; Li QP; Xiao SJ; Cai JZ
Trials; 2015 Apr; 16():146. PubMed ID: 25873045
[TBL] [Abstract][Full Text] [Related]
17. Effects of Shenmai injection combined with platinum-containing first-line chemotherapy on quality of life, immune function and prognosis of patients with nonsmall cell lung cancer: A protocol for systematic review and meta-analysis.
Chen Y; Zhang C; Pan C; Yang Y; Liu J; Lv J; Pan G
Medicine (Baltimore); 2021 Nov; 100(44):e27524. PubMed ID: 34871214
[TBL] [Abstract][Full Text] [Related]
18. [Chinese herbal medicine for side effects of transarterial chemoembolization in liver cancer patients: a systematic review and meta-analysis].
Li XQ; Ling CQ
Zhong Xi Yi Jie He Xue Bao; 2012 Dec; 10(12):1341-62. PubMed ID: 23257126
[TBL] [Abstract][Full Text] [Related]
19. Chinese herbal medicine for endometriosis.
Flower A; Liu JP; Lewith G; Little P; Li Q
Cochrane Database Syst Rev; 2012 May; (5):CD006568. PubMed ID: 22592712
[TBL] [Abstract][Full Text] [Related]
20. First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer.
Greenhalgh J; Boland A; Bates V; Vecchio F; Dundar Y; Chaplin M; Green JA
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD010383. PubMed ID: 33734432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
